The global weight-loss drug market is entering a new phase, driven by the arrival of oral options, looming generic rivals and falling U.S. prices for blockbuster treatments from Eli Lilly and Novo ...

Zealand and Roche are jointly developing the drug petrelintide which in a mid-stage study led to a worse-than-expected 10.7% ...

A new study reports that GLP-1 semaglutide medications may help reverse the effects of osteoarthritis in the joints by ...

The Green Bay Packers made the decision to cut All-Pro cornerback Trevon Diggs over the offseason after the team lost to the Chicago Bears in the Wild Card round. Diggs joined the Packers in December ...

What started with Ozempic has become a new era in weight-loss success with blockbuster GLP-1 drugs like Wegovy and Zepbound helping fight obesity. But they’re just the beginning. New treatments that ...

Airlines could have weight loss drug manufacturers to thank for savings if passengers become lighter, allowing carriers to spend less money on fuel. As GLP-1 medications for weight loss become ...

Many people who use these medications don’t want to stay on them long term. But research has repeatedly shown that quitting the drugs means gaining back weight. By Dani Blum Weight-loss drugs like ...

Wall Street is finding an unexpected beneficiary of America's weight loss boom: airlines. With the first GLP-1 weight loss drug now available in pill form, analysts at Jefferies say broad adoption ...

GLP-1 has become a popular buzzword in the weight-loss community — but now some are touting "GLP-3s," claiming they are taking obesity medications to the next level. GLP-1 (glucagon-like peptide-1) ...

Share on Pinterest The Food and Drug Administration (FDA) recently approved a tablet version of the GLP-1 drug Wegovy for weight loss. Image courtesy of Novo Nordisk Novo Nordisk officials said a new ...

A pill version of the blockbuster weight-loss medication Wegovy is rolling out in the U.S., and people are already actively navigating prescriptions. Experts say that a pill version of the high-demand ...

Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including Wegovy and Zepbound are expected to be easier to access and afford. And new ...